ロード中...
Second-Generation Antimitotics in Cancer Clinical Trials
Mitosis represents a promising target to block cancer cell proliferation. Classical antimitotics, mainly microtubule-targeting agents (MTAs), such as taxanes and vinca alkaloids, are amongst the most successful anticancer drugs. By disrupting microtubules, they activate the spindle assembly checkpoi...
保存先:
| 出版年: | Pharmaceutics |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8309102/ https://ncbi.nlm.nih.gov/pubmed/34371703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13071011 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|